ROSUMIN TAB. 20MG

Efficacy/Effectiveness

Antilipidemic agents
1.Primary hyperlipidemia or Mixed dyslipidemia(type llb)
2.Homozygous familial hypercholesterolemia
3.Reducing the risk of atherosclerosis by lowering total cholesterol levels and LDL(low-density lipoprotein) cholesterol levels.
4.Heterozygous familial hypercholesterolemia
5.Primary dysbetalipoproteinemia
6.Reducing the risk of cardiovascular diseases

ROSUMIN TAB. 10MG

Efficacy/Effectiveness

Antilipidemic agents
1.Primary hyperlipidemia or Mixed dyslipidemia(type llb)
2.Homozygous familial hypercholesterolemia
3.Reducing the risk of atherosclerosis by lowering total cholesterol levels and LDL(low-density lipoprotein) cholesterol levels.
4.Heterozygous familial hypercholesterolemia
5.Primary dysbetalipoproteinemia
6.Reducing the risk of cardiovascular diseases

ROSUMIN TAB. 5MG

Efficacy/Effectiveness

Antilipidemic agents
1.Primary hyperlipidemia or Mixed dyslipidemia(type llb)
2.Homozygous familial hypercholesterolemia
3.Reducing the risk of atherosclerosis by lowering total cholesterol levels and LDL(low-density lipoprotein) cholesterol levels.
4.Heterozygous familial hypercholesterolemia
5.Primary dysbetalipoproteinemia
6.Reducing the risk of cardiovascular diseases

APITO TAB. 20MG

Efficacy/Effectiveness

Antilipidemic agents
Reduction of elevated cholesterol & triglyceride levels if other measures eg diet, exercise, wt reduction have been unsuccessful in patients with
primary hypercholesterolaemia or mixed hyperlipidaemia (Fredrickson types IIa & IIb), hereditary familial heterozygous or homozygous hypercholesterolaemia

APITO TAB. 10MG

Efficacy/Effectiveness

Antilipidemic agents
Reduction of elevated cholesterol & triglyceride levels if other measures eg diet, exercise, wt reduction have been unsuccessful in patients with
primary hypercholesterolaemia or mixed hyperlipidaemia (Fredrickson types IIa & IIb), hereditary familial heterozygous or homozygous hypercholesterolaemia